Congress Wealth Management LLC / DE / »

Context Therapeutics shares owned by Congress Wealth Management LLC / DE /

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Congress Wealth Management LLC / DE / from 13F filings

Historical chart of Congress Wealth Management LLC / DE / investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Congress Wealth Management LLC / DE / consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Congress Wealth Management LLC / DE /

Quarter filed Position value Share count Share price at filing
2025-06-30 $9.8k 15k 0.66
2025-03-31 $9.2k 15k 0.61

More positions owned by Congress Wealth Management LLC / DE /

Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Financial (XLF)
Meta Platforms Cl A (META)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Janus Detroit Str Tr Henderson Securi (JSI)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Select Sector Spdr Tr Communication (XLC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
Visa Com Cl A (V)

View all positions for Congress Wealth Management LLC / DE /

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Avidity Partners Management
Deep Track Capital
Nextech Invest
Blue Owl Capital Holdings
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Vanguard Group
Blackstone Group
Alyeska Investment Group
Nantahala Capital Management
Sio Capital Management
BlackRock
Geode Capital Management
Affinity Asset Advisors

View all funds holding Context Therapeutics